Article Details

Nascent Biotech, Inc. (OTCMKTS:NBIO) Short Interest Update - Defense World

Retrieved on: 2022-05-26 15:26:25

Tags for this article:

Click the tags to see associated articles and topics

Nascent Biotech, Inc. (OTCMKTS:NBIO) Short Interest Update - Defense World. View article details on hiswai:

Excerpt

It is developing Pritumumab, a monoclonal antibody to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up